Abstract-Disturbances in the regulation of cytosolic calcium (Ca 2ϩ ) concentration play a key role in the vascular dysfunction associated with arterial hypertension. Stromal interaction molecules (STIMs) and Orai proteins represent a novel mechanism to control store-operated Ca 2ϩ entry. Although STIMs act as Ca 2ϩ sensors for the intracellular Ca 2ϩ stores, Orai is the putative pore-forming component of Ca 2ϩ release-activated Ca 2ϩ channels at the plasma membrane. We hypothesized that augmented activation of Ca 2ϩ release-activated Ca 2ϩ /Orai-1, through enhanced activity of STIM-1, plays a role in increased basal tonus and vascular reactivity in hypertensive animals. Endothelium-denuded aortic rings from Wistar-Kyoto and stroke-prone spontaneously hypertensive rats were used to evaluate contractions because of Ca 2ϩ influx. Depletion of intracellular Ca 2ϩ stores, which induces Ca 2ϩ release-activated Ca 2ϩ activation, was performed by placing arteries in Ca 2ϩ free-EGTA buffer. The addition of the Ca 2ϩ regular buffer produced greater contractions in aortas from stroke-prone spontaneously hypertensive rats versus Wistar-Kyoto rats. Thapsigargin (10 mol/L), an inhibitor of the sarcoplasmic reticulum Ca 2ϩ ATPase, further increased these contractions, especially in stroke-prone spontaneously hypertensive rat aorta. Addition of the Ca 2ϩ release-activated Ca 2ϩ channel inhibitors 2-aminoethoxydiphenyl borate (100 mol/L) or gadolinium (100 mol/L), as well as neutralizing antibodies to STIM-1 or Orai-1, abolished thapsigargin-increased contraction and the differences in spontaneous tone between the groups. Expression of Orai-1 and STIM-1 proteins was increased in aorta from stroke-prone spontaneously hypertensive rats when compared with Wistar-Kyoto rats. These results support the hypothesis that both Orai-1 and STIM-1 contribute to abnormal vascular function in hypertension. Augmented activation of STIM-1/Orai-1 may represent the mechanism that leads to impaired control of intracellular Ca 2ϩ levels in hypertension. 
Abstract-Disturbances in the regulation of cytosolic calcium (Ca 2ϩ ) concentration play a key role in the vascular dysfunction associated with arterial hypertension. Stromal interaction molecules (STIMs) and Orai proteins represent a novel mechanism to control store-operated Ca 2ϩ entry. Although STIMs act as Ca 2ϩ sensors for the intracellular Ca 2ϩ stores, Orai is the putative pore-forming component of Ca 2ϩ release-activated Ca 2ϩ channels at the plasma membrane. We hypothesized that augmented activation of Ca 2ϩ release-activated Ca 2ϩ /Orai-1, through enhanced activity of STIM-1, plays a role in increased basal tonus and vascular reactivity in hypertensive animals. Endothelium-denuded aortic rings from Wistar-Kyoto and stroke-prone spontaneously hypertensive rats were used to evaluate contractions because of Ca 2ϩ influx. Depletion of intracellular Ca 2ϩ stores, which induces Ca 2ϩ release-activated Ca 2ϩ activation, was performed by placing arteries in Ca 2ϩ free-EGTA buffer. The addition of the Ca 2ϩ regular buffer produced greater contractions in aortas from stroke-prone spontaneously hypertensive rats versus Wistar-Kyoto rats. Thapsigargin (10 mol/L), an inhibitor of the sarcoplasmic reticulum Ca 2ϩ ATPase, further increased these contractions, especially in stroke-prone spontaneously hypertensive rat aorta. Addition of the Ca 2ϩ release-activated Ca 2ϩ channel inhibitors 2-aminoethoxydiphenyl borate (100 mol/L) or gadolinium (100 mol/L), as well as neutralizing antibodies to STIM-1 or Orai-1, abolished thapsigargin-increased contraction and the differences in spontaneous tone between the groups. Expression of Orai-1 and STIM-1 proteins was increased in aorta from stroke-prone spontaneously hypertensive rats when compared with Wistar-Kyoto rats. These results support the hypothesis that both Orai-1 and STIM-1 contribute to abnormal vascular function in hypertension. Augmented activation of STIM-1/Orai-1 may represent the mechanism that leads to impaired control of intracellular Ca 2ϩ levels in hypertension. The subsequent prolonged increase requires extracellular Ca 2ϩ influx through various pathways. In smooth muscle cells (SMCs), Ca 2ϩ entry mechanisms responsible for sustained cellular activation are normally mediated by either voltage-operated or receptor-operated Ca 2ϩ channels. [3] [4] [5] Depletion of ER Ca 2ϩ stores is able to gate the entry of extracellular Ca 2ϩ . 6, 7 This mechanism, by which the ER acts as a capacitor, leads to the term "store-operated Ca 2ϩ (SOC) entry." 6, 7 Recently, the discoveries of the stromal interacting molecules (STIMs) 8, 9 and Orai proteins 10, 11 have provided important information into the possible mechanisms by which this process is regulated.
STIMs are a family of single-transmembrane domain proteins found both in the plasma membrane and the ER, and their involvement with Ca 2ϩ entry regulation has been described recently. It has been proposed that one of its isoforms, STIM-1, functions as a sensor for the ER Ca 2ϩ . The suppression of STIM-1 expression prevents SOC entry and eliminates the store-dependent activation of Ca 2ϩ release-activated Ca 2ϩ (CRAC) channels. Furthermore, Ca 2ϩ depletion from ER results in a profound intracellular redistribution of STIM-1, from a uniform ER pattern to spatially discrete areas close to the plasma membrane. 12, 13 Another protein family, Orai, which presently has 3 members, seems to be an essential component of CRAC channels, and Orai-1 has been suggested to be the pore-forming component of CRAC channels. 10 In addition, STIM-1 and Orai-1 are sufficient for the generation of functional CRAC channels. 12, 14 Ca 2ϩ is elevated in various cells from patients with hypertension and from spontaneously hypertensive rats. Because Ca 2ϩ is a central component in the control of vascular contraction, abnormal handling of this cation by vascular myocytes has been suggested to account for the increased responses of vascular SMCs (VSMCs) to constrictor stimuli and augmented myogenic tone, [15] [16] [17] [18] [19] key markers of arterial hypertension.
The magnitude of contraction is associated with the concentration of free Ca ϩ2 . So, we used the contractile responses to reflect vascular Ca ϩ2 influx or mobilization. This technique has been validated by Karaki et al 20 and previous work from our laboratory. 21, 22 In addition, the development of active tone in stroke-prone spontaneously hypertensive rat (SHRSP) aortas is brought by changes in Ca ϩ2 influx, and changes in tone and intracellular Ca 2ϩ levels are positively correlated. 23 Therefore, considering that hypertension is associated with an imbalance in Ca 2ϩ homeostasis, and STIM and Orai proteins seem to be fundamental to intracellular Ca 2ϩ regulation, we hypothesized that increased activation of CRAC/ Orai-1, through the Ca 2ϩ sensor STIM-1, plays a role in augmented reactivity in aortas from hypertensive animals.
Methods Animals
Five-to 6-month-old male SHRSPs were obtained from the breeding colony at the Medical College of Georgia. Age-matched male Wistar-Kyoto (WKY) rats were purchased from Harlan (Indianapolis Ind). Rats were maintained on a 12-hour light:dark cycle, housed 2 per cage, and allowed access to normal chow and water ad libitum. Systolic blood pressure was measured in nonanesthetized animals by tail cuff using a RTBP1001 blood pressure system (Kent Scientific Corporation). All of the procedures were performed in accordance with the Guiding Principles in the Care and Use of Animals, approved by the Medical College of Georgia Committee on the Use of Animals in Research and Education.
Vascular Functional Studies
After euthanasia, thoracic aortas were rapidly excised and placed in ice-chilled (Ϸ4°C) physiological salt solution. Segments of thoracic aorta were carefully dissected, and the endothelium was removed by gently rubbing the lumen side of the vessels with a metallic pin. Aortic rings (4 mm in length) were mounted on 2 stainless-steel wires in standard organ chambers (model 610 mol/L, Danish MyoTech) for isometric tension recording, as described previously. 21, 22 After stabilization, arterial integrity was assessed first by stimulation of vessels with 120 mmol/L of KCl and, after washing and a new stabilization period, by contracting the segments with phenylephrine (PE; 1 mol/L). Endothelium denudation was assessed by the absence of a relaxation response to acetylcholine (1 mol/L) during PE-induced contraction. 
Experimental Protocols
Force development in response to a specific experimental protocol was evaluated in aortas from both rat groups, as described in Figure  1 . Briefly, aortic rings were contracted with PE (1 mol/L). When the contraction reached a plateau, aortas were washed in Ca 2ϩ free-EGTA buffer, to deplete intracellular Ca 2ϩ stores (depletion period), for 20 minutes. During the depletion period, aortas were incubated with vehicle or thapsigargin (1 mol/L, a putative selective Ca 2ϩ -ATPase inhibitor), and some rings were treated with nonselective CRAC channel blockers, 2-aminoethoxydiphenyl borate (2-APB, 100 mol/L) or gadolinium (Gd 3ϩ ; 100 mol/L). After Ca 2ϩ depletion, intracellular Ca 2ϩ stores were loaded (loading period) by placing the aortas in 1.6 mmol/L of Ca 2ϩ buffer for 15 minutes. Contraction responses during the loading period were determined. The bathing medium was then replaced with Ca 2ϩ -free buffer, and after 2 minutes, the aortic segments were stimulated with caffeine (20 mmol/L) to deplete intracellular Ca 2ϩ stores, which resulted in a transient contraction. 20, 21 
Antibody Delivery by the Chariot Technique
Antibodies against STIM-1 and Orai-1 (ProSci) were intracellularly delivered by the Chariot technique (Chariot Protein Delivery Reagent, Active Motif). This transfection reagent is able to deliver antibodies into cells while preserving their ability to localize to the proper cellular compartment and to recognize antigens within the cell 24 -26 and in our experiments was used to directly inhibit STIM-1 and Orai-1 proteins. Chariot/antibody complexes were prepared and used according to the manufacturer's instructions. Briefly, aortic rings were incubated in Eagle's minimum essential medium containing L-glutamine (1.0%), FBS (10.0%), and penicillin and streptomycin (0.5%) for 30 minutes at 37°C. For each transfection, 12 L of Chariot in 100 L of 40% dimethyl sulfoxide were mixed with 6 g of antibody in 100 L of PBS and incubated at room temperature for 30 minutes to allow the complex to form. The aortas were transferred to a sterile 24-well cell culture plate, overlaid with 200 L of Chariot/antibody complex, and mixed gently. Eagle's minimum essential medium (400 L) was added, and the tissues were incubated for 1 hour at 37°C. Then, Eagle's minimum essential medium (750 L) was added, and tissues were further incubated for 2 hours at 37°C. After this period, rings were mounted in the myograph, and functional studies were performed.
Western Blotting
Aortas from hypertensive and control rats were isolated, cleaned from fat, dissected, and frozen in liquid nitrogen. Extracted proteins (40 g) were separated by electrophoresis on a 10% polyacrylamide gel and transferred to a nitrocellulose membrane. Nonspecific binding sites were blocked with 5% skim milk in Tris-buffered saline solution with Tween (0.1%) for 1 hour at 24°C. Membranes were then incubated with antibodies overnight at 4°C. Antibodies were as follows: anti-STIM-1 and anti-Orai-1 (1:1000, ProSci), as well as ␤-actin (1:1000, Sigma-Aldrich). Human ovary and mouse thymus tissue lysate (ProSci) were used as positive controls for STIM-1 and Orai-1, respectively. After incubation with secondary antibodies, signals were revealed with chemiluminescence, visualized by autoradiography, and quantified densitometrically. Results were normalized by ␤-actin expression and expressed as units of change from the control.
RNA Extraction, cDNA Synthesis, and Quantitative Real-Time RT-PCR
Total RNA was extracted from aorta using the RNeasy kit (Qiagen Sciences). The quantity, purity, and integrity of all of the RNA samples were determined by NanoDrop spectrophotometry (NanoDrop Technologies). One microgram of total RNA was reverse transcribed in a final volume of 50 L using the High-Capacity cDNA Archive kit (Applied Biosystems), and single-strand cDNA was stored at Ϫ20°C. Primers for STIM-1 (catalog No. Rn00968446m1) and Orai-1 (catalog No. Rn02397170m1) mRNA were obtained from Applied Biosystems. Real-time RT-PCR (quantitative PCR) reactions were performed using the 7500 Fast RealTime PCR System (Applied Biosystems) in a total volume of 20 L of reaction mixture following the manufacturer's protocol, using TaqMan Fast Universal PCR Master Mix (2ϫ; Applied Biosystems), and 0.1 mol/L of each primer. Negative controls contained water instead of first-strand cDNA. Each sample was normalized on the basis of its 18S ribosomal RNA content. The 18S quantification was performed using a TaqMan Ribosomal RNA Reagent kit (Applied Biosystems), following the manufacturer's protocol. Relative gene expression for STIM-1 and Orai-1 mRNA was normalized to a calibrator that was chosen to be the basal condition (untreated sample) for each time point. Results were calculated with the ⌬⌬Ct method and expressed as n-fold differences in preproET-1 gene expression relative to 18S rRNA and to the calibrator and were determined as follows: n-foldϭ2 Ϫ(⌬ Ct sample Ϫ⌬ Ct calibrator ) , where the parameter Ct (threshold cycle) is defined as the fractional cycle number at which the PCR reporter signal passes a fixed threshold. ⌬Ct values of the sample and the calibrator were determined by subtracting the average Ct value of the transcript under investigation from the average Ct value of the 18S rRNA gene for each sample.
Immunofluorescence Microscopy Analysis
STIM-1 and Orai-1 expression in endothelium-denuded aortas from SHRSPs and WKY rats was determined by immunofluorescence staining technique. Aortas were frozen in optimal cutting temperature, and sections were obtained. Briefly, aorta sections were washed with PBS with 0.2% Triton X (PBS-T) for 15 minutes at room temperature and fixed in acetone for 5 minutes at Ϫ20°C, and nonspecific binding sites were blocked with PBS-T plus 1% BSA for 10 minutes at room temperature and with 10% goat serum in PBS-T/BSA for 30 minutes at room temperature. Subsequently, STIM-1 and Orai-1 expression was determined by incubating the vascular sections with anti-STIM-1 (1:100, rabbit polyclonal, ProSCi) and anti-Orai-1 (1:100, mouse polyclonal, Abcon), respectively, overnight at 4°C. Aortic sections were then placed at room temperature, rinsed with PBS-T for 15 minutes, probed with goat antimouse Alexa Fluor 588, (1:1000, green fluorescence, Invitrogen) and probed with goat antirabbit Alexa Fluor 568 (1:1000, red fluorescence, Invitrogen), which was followed by another rinse with TBS-T. Images were acquired with the use of the confocal microscope (LSM 510 Meta 3.2, Zeiss). Magnification power was set at ϫ10.
Drugs and Solutions
Physiological salt solution of the following composition was used: 130 mmol/L NaCl, 14.9 mmol/L NaHCO 3 , 4.7 mmol/L KCl, 1.18 mmol/L KH 2 PO 4 , 1.17 mmol/L MgSO 4 ⅐ 7 H 2 O, 5.5 mmol/L glucose, 1.56 mmol/L CaCl 2 ⅐ 2 H 2 O, and 0.026 mmol/L EDTA. PE and acetylcholine were purchased from Sigma Chemical Co. All of the reagents were of analytic grade. Stock solutions were prepared in deionized water. Control solutions containing vehicle (DMSO) were also used through the experimental protocols.
Data Analysis
Results are presented as meansϮSEMs. Contractions were recorded as changes in the displacement (mN) from baseline and are represented as mN per number of experiments. Statistically significant differences were calculated by ANOVA (Newman-Keuls posthoc test) or by Student's t test where appropriate. PϽ0.05 was considered significant.
of SHRSPs was significantly lower (296.0Ϯ6.1 g; nϭ15) when compared with WKY rats (345.0Ϯ5.2 g; nϭ15).
Force Development During the Ca

2؉
Loading Period Figure 1 illustrates the protocol used to evaluate force development in response to Ca 2ϩ influx after depletion of intracellular Ca 2ϩ stores (loading period) and after caffeine stimulation to measure the functional capacity of the sarcoplasmic reticulum (SR) to release Ca 2ϩ . After an initial response to 120 mmol/L of KCl (SHRSP, 14.1Ϯ3.2 mN versus WKY, 22.7Ϯ5.3 mN; nϭ10) and a new stabilization period, aortas were stimulated with PE (1 mol/L), and the contraction was allowed to reach a plateau. PE-induced contractions were similar in aortas from SHRSPs (20.8Ϯ1.7 mN; nϭ12) compared with WKY rats (15.6Ϯ2.7 mN; nϭ12). After PE contraction, aortas were washed in Ca 2ϩ free-EGTA buffer either in the absence ( Figure 1A and 1B, vehicle) or presence ( Figure 1C and 1D ) of thapsigargin (1 mol/L). Figure 2A shows that, during the Ca 2ϩ -loading period, force development was augmented in aortas from SHRSPs (10.0Ϯ0.9 mN; nϭ6) compared with WKY rats (4.8Ϯ1.0 mN; nϭ6). CRAC channel blockade with 2-APB and Gd 3ϩ significantly inhibited contraction in SHRSP aortas during the Ca 2ϩ loading period (3.9Ϯ0.6 and 6.3Ϯ0.4 mN, respectively) but had no significant effects in WKY aortas.
Thapsigargin was used to inhibit the SR Ca 2ϩ -ATPase and to promote the depletion of intracellular Ca 2ϩ stores. Accordingly, this would result in continuous stimulation of the SR Ca 2ϩ sensor, STIM-1, and, consequently, activation of SOC entry through CRAC channels. As shown in Figure 2B , thapsigargin incubation augmented contractions during the Ca 2ϩ loading period in aortic rings from both groups. However, contractions were greater in SHRSP aortas (16.5Ϯ0.9 mN versus WKY, 10.7Ϯ1.0 mN; nϭ6). During thapsigargin incubation, simultaneous inhibition of CRAC channels by 2-APB and Gd 3ϩ significantly decreased Ca 2ϩ loading-induced contractions both in WKY rats (2.4Ϯ0.2 and 4.3Ϯ0.9 mN, respectively) and SHRSPs (3.9Ϯ0.1 and 5.9Ϯ0.4 mN, respectively), abolishing the differences between the groups. Collectively, these results suggest that CRAC channel activation is increased in aortas from the hypertensive animals, contributing to augmented extracellular Ca 2ϩ influx.
As an alternative approach to the pharmacological inhibition with 2-APB and Gd ϩ3 , neutralizing antibodies against STIM-1 and Orai-1 were intracellularly delivered by the Chariot technique. Figure 3A shows that transfection with Orai-1 or STIM-1 antibodies resulted in decreased contraction during the Ca 2ϩ loading period in both groups, indicating that activations of STIM-1 and Orai-1 are required for SOC entry, even in physiological conditions. After transfection, contractile responses in SHRSP aortas were similar to those in the control group, reinforcing the notion that these proteins play a role in augmented tone development in vessels from SHRSPs. On thapsigargin inhibition, anti-Orai-1 and anti- STIM-1 antibody transfection decreased contractile responses during the Ca 2ϩ loading period in SHRSP aortas, whereas only a small reduction was observed in vessels from WKY rats ( Figure 3B) . Empty Chariot or incubation of vessels with all of the reagents used in the Chariot protocol except antibodies, as well as the addition of a nonspecific antibody (antimouse IgG) to the empty Chariot, were used as additional controls and did not produce any significant effects. We speculate that increased CRAC channel activation in aortas from hypertensive rats, through mechanisms dependent on STIM-1 and Orai-1 activation, results in exacerbated extracellular Ca 2ϩ influx and augmented spontaneous tone on the depletion of intracellular Ca 2ϩ stores.
Intracellular Ca 2؉ Stores Depletion
The functional capacity of the SR to release Ca 2ϩ was evaluated by placing the aortas in Ca 2ϩ -free buffer for 2 minutes and by stimulation with caffeine (20 mmol/L). As observed in Figure 4A , SHRSP aortas displayed increased caffeine-induced contractions compared with WKY rats. CRAC channel blockade with 2-APB and Gd 3ϩ during the Ca 2ϩ -loading period reduced contractions induced by caffeine, both in WKY rats and SHRSPs. On thapsigargin incubation, caffeine-induced contractions were already reduced compared with those in vehicle-treated vessels, but still greater in SHRSP aortas, confirming that inhibition of the SR Ca 2ϩ -ATPase activity decreases intracellular Ca 2ϩ storage. Caffeine-induced contractions were further reduced in aortas from both groups on CRAC channel blockade. Treatment with 2-APB and Gd 3ϩ practically abolished contractions in both groups ( Figure 4B ). These results confirm that CRAC channel activation contributes to SR Ca 2ϩ loading. Figure 5A shows that transfection of Orai-1 or STIM-1 antibodies decreased the SR Ca 2ϩ loading capacity, resulting in smaller transient contractions to caffeine in both groups. Furthermore, differences in caffeine-induced contractions between aortas from WKY rats and SHRSPs were abolished after transfection of Orai-1 or STIM-1 antibodies. On thapsigargin incubation, caffeine-induced contractions were decreased in vessels from SHRSPs and WKY rats, and no differences were found among the groups ( Figure 5B ). In this condition, transfection of Orai-1 or STIM-1 antibodies had no further effects. These data reinforce the suggestion that STIM-1 and Orai-1 activation is important during the SR Ca 2ϩ reloading period and indicate that aortas from hypertensive rats display increased activation of STIM-1 and Orai-1-related pathways.
STIM-1 and Orai-1 Expression
Aortas from SHRSPs exhibited increased protein levels of STIM-1 (1.61Ϯ0.14) and Orai-1 (1.23Ϯ0.06) compared with WKY rats (Figure 6A-B) . In addition, STIM-1 and Orai-1 mRNA levels were augmented in aortas from SHRSPs (1.25Ϯ0.1 and 1.69Ϯ0.3, respectively) compared with WKY rats (Figure 6C and 6D) . Immunohistochemistry analysis confirmed increased expression of STIM-1, but not Orai-1, in aortas from SHRSPs in comparison with WKY rats ( Figure 6E ).
Discussion
In smooth muscle, the activation of SOC entry is key to mediating long-term cytosolic Ca 2ϩ signals and replenishing intracellular Ca 2ϩ stores. 6, 27, 28 In many cell types, SOC entry carries a highly Ca 2ϩ -selective, nonvoltage-gated, inwardly rectifying current termed the "CRAC current." 7, 27, 28 A defect in the regulation of Ca 2ϩ plays a role in the increased vascular reactivity in hypertension. The cellular mechanisms involved in abnormal Ca 2ϩ handling in VSMCs are numerous and include increased Ca 2ϩ entry, increased Ca 2ϩ storage in the SR, or decreased Ca 2ϩ extrusion. In this article, we focused on the possibility that increased Ca 2ϩ influx mediated by a defective signal from intracellular Ca 2ϩ stores contributes to abnormal vascular reactivity in hypertension. Increased activation of CRAC/Orai-1, through the Ca 2ϩ sensor STIM-1, plays a role in augmented reactivity in aortas from hypertensive animals.
Augmented Ca 2ϩ levels in SMCs from spontaneously hypertensive rats 29 31 Furthermore, calreticulin is elevated in peripheral maternal blood during preeclampsia in humans, 32 and cardiac hypertrophy causes alterations in the SR Ca 2ϩ -storing proteins, a mechanism that may contribute to the contractile dysfunction of hypertrophied cardiac myocytes. 33 A correlation between increased levels of calreticulin/calsequestrin and increased risk of adult heart disease has also been established. 34 A third mechanism is represented by alterations in the Ca 2ϩ ER sensor, STIM-1, which modulates/activates Ca 2ϩ entry. SOC entry in SMCs involves functional STIM-1 proteins, which, on activation, translocate to plasma membrane domains and activate Ca 2ϩ entry, similarly to what has been described in other tissues. [35] [36] [37] Recent literature has identified STIM and Orai proteins as key signaling players in the activation of SOC in a number of inflammatory cell types. Orai-1 protein fulfills all of the criteria of being the SOC moiety itself. 11,13,14,38 -41 In addition, combined expression of STIM-1 and Orai-1 resulted in a huge gain of SOC function and indicates that the 2 proteins are likely sufficient to mediate the operation of SOCs. 13, 14, 38, 39 Peel et al 42 showed that Orai-1 small interfering RNA transfection on whole airway SMCs blocks inward currents initiated by Ca 2ϩ store depletion. They found a similar result by using inhibitors of SOC Ca 2ϩ influx, including 2-APB, Gd 3ϩ , and lanthanum. In addition, mutations in Orai-1 also result in significant changes to the electrophysiology properties of CRAC current, rendering the current less Ca 2ϩ selective with outward rectification. 11 Such studies have provided evidence for the theory that Orai-1 forms the pore-forming subunits of the CRAC channel. Orai-1 and STIM-1 may also contribute to the function of other SOC channels. 43 In this sense, Orai-1 has been reported to interact with the TRPC1 channel and forms a ternary complex along with STIM-1 in the plasma membrane. 44, 45 Nailing down the identity of both the sensor and the channel itself has created new possibilities in the Ca 2ϩ signaling field. Considering that defects in Ca 2ϩ handling in VSMCs are among the candidate cellular mechanisms for the pathogenesis of hypertension, STIM-1/Orai-1 represent important components to the intracellular Ca 2ϩ regulation, and STIM-1/Orai activation in VSMCs from hypertensive animals has not been addressed, we hypothesized that increased activation of CRAC/Orai-1, through the Ca 2ϩ sensor STIM-1, plays a role in augmented reactivity in aortas from hypertensive animals. As evidenced by our results, CRAC channel activation is increased in aortas from SHRSPs by mechanisms dependent on STIM-1 and Orai-1 activation, resulting in augmented extracellular Ca 2ϩ influx, inferred from spontaneous enhancement in contractile function.
We described previously that aortas from SHRSPs displayed increased force development during the Ca 2ϩ -loading period on the depletion of intracellular Ca 2ϩ stores. 22 The SR Ca 2ϩ store is larger in aortas from SHRSPs because of an enhanced influx of Ca 2ϩ across the sarcolemma rather than an impaired recycling of the cation by the SR Ca 2ϩ -ATPase. 42 This study shows that prevention of STIM-1 activation by neutralizing antibodies prevents contractions induced by Ca 2ϩ influx during the Ca 2ϩ loading period. Neutralization of Orai-1 also decreased Ca 2ϩ influx, as indicated by our functional experiments. Furthermore, thapsigargin-mediated vascular Ca 2ϩ influx was greatly reduced by transfection of STIM-1 and Orai-1 antibodies compared with that in negative transfected aortas.
2-APB, a nonselective blocker, and Gd 3ϩ , a selective and irreversible blocker of CRAC channels, were used to inhibit SOC entry. 46 2-APB and Gd 3ϩ inhibited Ca 2ϩ entry, as evidenced by inhibition of contractile responses, in aortas from WKY rats and SHRSPs. The differences in spontaneous tone development during the Ca 2ϩ -loading period between the groups were abolished after CRAC channel blockade. These results demonstrate that CRAC channels represent an important pathway for Ca 2ϩ entry and that CRAC activation is enhanced in aortas from SHRSPs compared with that in WKY rats.
Possible mechanisms associated with an abnormal function of the Ca 2ϩ sensor STIM-1 and CRAC channels include increased expression or activity of these proteins, defective activation of the sensor by Ca 2ϩ , or augmented activation/ decreased inactivation of CRAC channels. In this study, we have observed that aortas from SHRSPs display increased expression of both STIM-1 and Orai-1. Although it is possible that increased protein levels may account for the increased functional contractile responses observed after intracellular Ca 2ϩ depletion, other mechanisms may need to be taken into consideration.
Perspectives
Most of the work related to the characterization of STIM-1 and Orai-1 was performed in lymphocytes and T cells. A mutation in Orai-1 was observed in patients with severe combined immune deficiency, resulting in abrogated CRAC channel function. 10 The effect of the mutation in the Orai-1 was not reverted by overexpression of Orai-2 or Orai-3. This important article showed that alterations in Orai-1 are related to pathophysiological conditions and called the attention of pharmaceutical companies that have begun to investigate CRAC channel blockers as an option to reduce the toxicity of immunosuppressant drugs, such as cyclosporine A. 40, 47 Here we show for the first time that STIM-1 and Orai-1 proteins are upregulated in vessels from hypertensive animals. Functional upregulation of SOC in vessels from SHRSPs was confirmed both by pharmacological and molecular approaches. CRAC channel inhibitors may represent a new therapeutic approach to treat vascular dysfunction or to prevent end-organ damage associated with arterial hypertension.
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